Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gerhard Randers-Pehrson is active.

Publication


Featured researches published by Gerhard Randers-Pehrson.


PLOS ONE | 2013

207-nm UV Light-A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. II: In-Vivo Safety Studies.

Manuela Buonanno; Milda Stanislauskas; Brian Ponnaiya; Alan Bigelow; Gerhard Randers-Pehrson; Yanping Xu; Igor Shuryak; Lubomir B. Smilenov; David M. Owens; David J. Brenner

Background UVC light generated by conventional germicidal lamps is a well-established anti-microbial modality, effective against both bacteria and viruses. However, it is a human health hazard, being both carcinogenic and cataractogenic. Earlier studies showed that single-wavelength far-UVC light (207 nm) generated by excimer lamps kills bacteria without apparent harm to human skin tissue in vitro. The biophysical explanation is that, due to its extremely short range in biological material, 207 nm UV light cannot penetrate the human stratum corneum (the outer dead-cell skin layer, thickness 5–20 μm) nor even the cytoplasm of individual human cells. By contrast, 207 nm UV light can penetrate bacteria and viruses because these cells are physically much smaller. Aims To test the biophysically-based hypothesis that 207 nm UV light is not cytotoxic to exposed mammalian skin in vivo. Methods Hairless mice were exposed to a bactericidal UV fluence of 157 mJ/cm2 delivered by a filtered Kr-Br excimer lamp producing monoenergetic 207-nm UV light, or delivered by a conventional 254-nm UV germicidal lamp. Sham irradiations constituted the negative control. Eight relevant cellular and molecular damage endpoints including epidermal hyperplasia, pre-mutagenic UV-associated DNA lesions, skin inflammation, and normal cell proliferation and differentiation were evaluated in mice dorsal skin harvested 48 h after UV exposure. Results While conventional germicidal UV (254 nm) exposure produced significant effects for all the studied skin damage endpoints, the same fluence of 207 nm UV light produced results that were not statistically distinguishable from the zero exposure controls. Conclusions As predicted by biophysical considerations and in agreement with earlier in vitro studies, 207-nm light does not appear to be significantly cytotoxic to mouse skin. These results suggest that excimer-based far-UVC light could potentially be used for its anti-microbial properties, but without the associated hazards to skin of conventional germicidal UV lamps.


Scientific Reports | 2018

Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases

David Welch; Manuela Buonanno; Veljko Grilj; Igor Shuryak; Connor Crickmore; Alan Bigelow; Gerhard Randers-Pehrson; Gary W. Johnson; David J. Brenner

Airborne-mediated microbial diseases such as influenza and tuberculosis represent major public health challenges. A direct approach to prevent airborne transmission is inactivation of airborne pathogens, and the airborne antimicrobial potential of UVC ultraviolet light has long been established; however, its widespread use in public settings is limited because conventional UVC light sources are both carcinogenic and cataractogenic. By contrast, we have previously shown that far-UVC light (207–222u2009nm) efficiently inactivates bacteria without harm to exposed mammalian skin. This is because, due to its strong absorbance in biological materials, far-UVC light cannot penetrate even the outer (non living) layers of human skin or eye; however, because bacteria and viruses are of micrometer or smaller dimensions, far-UVC can penetrate and inactivate them. We show for the first time that far-UVC efficiently inactivates airborne aerosolized viruses, with a very low dose of 2u2009mJ/cm2 of 222-nm light inactivating >95% of aerosolized H1N1 influenza virus. Continuous very low dose-rate far-UVC light in indoor public locations is a promising, safe and inexpensive tool to reduce the spread of airborne-mediated microbial diseases.


Light-Based Diagnosis and Treatment of Infectious Diseases | 2018

Far-UVC light applications: sterilization of MRSA on a surface and inactivation of aerosolized influenza virus

David Welch; Henry M. Spotnitz; David J. Brenner; Gerhard Randers-Pehrson; Manuela Buonanno; Igor Shuryak

Methicillin-resistant Staphylococcus aureus (MRSA) and influenza A virus are two of the major targets for new antimicrobial technologies. In contrast to conventional germicidal lamps emitting primarily at 254 nm, which are both carcinogenic and cataractogenic, recent work has shown the potential of far-UVC technology, mainly between 207 and 222 nm, to be an effective means of sterilization of pathogens without apparent harm to mammalian cells. This is because, due to its strong absorbance in biological materials, far-UVC light cannot penetrate even the outer (non living) layers of human skin or eye; however, because bacteria and viruses are of micrometer or smaller dimensions, far-UVC can penetrate and inactivate them. With this report, we present progress on in vitro tests to inactivate MRSA on a surface using far-UVC light from a laser delivered using an optical diffuser. Qualitative and quantitative results show that this means of far-UVC exposure is adequate to inactivate MRSA with a dose comparable to that which would be required using a conventional germicidal lamp. Also included is a report on progress on inactivation of aerosolized influenza A virus. A custom benchtop aerosol exposure chamber was constructed and used to determine the effectiveness of far- UVC. Results indicate that far-UVC efficiently inactivates airborne aerosolized viruses, with a very low dose of 2 mJ/cm2 of 222-nm light inactivating >95% of aerosolized H1N1 influenza virus. Together these studies help to further establish far-UVC technology as a promising, safe and inexpensive tool for sterilization in many environments.


Archive | 1997

Substance detection device using monoenergetic neutrons

Gerhard Randers-Pehrson; David J. Brenner


Archive | 2018

Racetrack Fixed Field Alternating Gradient accelerator for variable energy extraction

Malek Haj Tahar; David J. Brenner; Gerhard Randers-Pehrson


Archive | 2016

Ultraviolet sleeves for percutaneous devices and methods for using and/or providing the same

Henry M. Spotnitz; David J. Brenner; Alan Bigelow; Gerhard Randers-Pehrson


Archive | 2009

DRAFT: RABIT - RAPID AUTOMATED BIODOSIMETRY TOOL FOR HIGH THROUGHPUT RADIOLOGICAL TRIAGE

Youhua Chen; Jian Zhang; Hongliang Wang; Guy Garty; Yanping Xu; Oleksandra V. Lyulko; Helen Turner; Gerhard Randers-Pehrson; Nabil Simaan; Y. Lawrence Yao; David J. Brenner


Archive | 2007

Systèmes et procédés de dosimétrie biologique de radiations à haut rendement

Anubha Bhatla; David J. Brenner; Aparajita Dutta; Guy Garty; Oleksandra V. Lyulko; Gerhard Randers-Pehrson; Alessio Salerno; Nabil Simaan; Y. Lawrence Yao; Jian Zhang


Archive | 2006

Radiation induced genomic instability in bystander cells

Honghui Zhou; Surrey Gu; Gerhard Randers-Pehrson; Tom K. Hei


Acta Medica Nagasakiensia | 2005

Contribution of Bystander Effects in Radiation Induced Genotoxicity

Hongning Zhou; Masao Suzuki; Rudranath Persaud; Joseph Gillispie; Gerhard Randers-Pehrson; Tom K. Hei

Collaboration


Dive into the Gerhard Randers-Pehrson's collaboration.

Top Co-Authors

Avatar

David J. Brenner

Columbia University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge